Literature DB >> 11842245

Topors, a p53 and topoisomerase I binding protein, interacts with the adeno-associated virus (AAV-2) Rep78/68 proteins and enhances AAV-2 gene expression.

Stefan Weger1, Eva Hammer1, Regine Heilbronn1.   

Abstract

The adeno-associated virus type 2 (AAV-2) Rep proteins are essential for AAV DNA replication and regulation of AAV gene expression. We have identified a cellular protein interacting with Rep78 and Rep68 in yeast two-hybrid analysis and in GST pull-down assays. This protein has recently been described as both a p53 (p53BP3) and a topoisomerase I interacting protein (Topors). It contains an arginine/serine-rich domain, a RING finger domain and five PEST sequences. A minimal sequence sufficient for interaction with Rep was mapped to Topors amino acids 871 to 917. We show that the same region is also involved in the interaction with p53. Rep sequences involved in interaction with Topors were mapped to Rep amino acids 172 to 481. Overexpression of Topors stimulated AAV gene expression in the absence of helper virus, suggesting a function of Topors as a transcriptional regulator.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11842245     DOI: 10.1099/0022-1317-83-3-511

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  15 in total

1.  DNA-binding activity of adeno-associated virus Rep is required for inverted terminal repeat-dependent complex formation with herpes simplex virus ICP8.

Authors:  Martin Alex; Stefan Weger; Mario Mietzsch; Heiko Slanina; Toni Cathomen; Regine Heilbronn
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

2.  Ubiquitination and degradation of mutant p53.

Authors:  Natalia Lukashchuk; Karen H Vousden
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

3.  Identification of an adeno-associated virus Rep protein binding site in the adenovirus E2a promoter.

Authors:  John M Casper; Jennifer M Timpe; John David Dignam; James P Trempe
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells.

Authors:  Chenxiao Yu; Jiao Xue; Wei Zhu; Yang Jiao; Shuyu Zhang; Jianping Cao
Journal:  Tumour Biol       Date:  2014-11-28

5.  Adeno-associated virus interactions with B23/Nucleophosmin: identification of sub-nucleolar virion regions.

Authors:  Joyce M Bevington; Patrick G Needham; Kristin C Verrill; Roy F Collaco; Venkatesh Basrur; James P Trempe
Journal:  Virology       Date:  2006-09-07       Impact factor: 3.616

6.  Studies of the mechanism of transactivation of the adeno-associated virus p19 promoter by Rep protein.

Authors:  Daniel F Lackner; Nicholas Muzyczka
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Mutations in TOPORS cause autosomal dominant retinitis pigmentosa with perivascular retinal pigment epithelium atrophy.

Authors:  Christina F Chakarova; Myrto G Papaioannou; Hemant Khanna; Irma Lopez; Naushin Waseem; Amna Shah; Torsten Theis; James Friedman; Cecilia Maubaret; Kinga Bujakowska; Brotati Veraitch; Mai M Abd El-Aziz; De Quincy Prescott; Sunil K Parapuram; Wendy A Bickmore; Peter M G Munro; Andreas Gal; Christian P Hamel; Valeria Marigo; Chris P Ponting; Bernd Wissinger; Eberhart Zrenner; Karl Matter; Anand Swaroop; Robert K Koenekoop; Shomi S Bhattacharya
Journal:  Am J Hum Genet       Date:  2007-09-26       Impact factor: 11.025

8.  Does control of mutant p53 by Mdm2 complicate cancer therapy?

Authors:  Carol Prives; Eileen White
Journal:  Genes Dev       Date:  2008-05-15       Impact factor: 11.361

9.  Identification of cellular proteins that interact with the adeno-associated virus rep protein.

Authors:  Kevin Nash; Weijun Chen; Max Salganik; Nicholas Muzyczka
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

10.  Role of E3 ubiquitin ligases in lung cancer.

Authors:  Barbara C Snoek; Leonie Ham de Wilt; Gerrit Jansen; Godefridus J Peters
Journal:  World J Clin Oncol       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.